Iterum Therapeutics (ITRM) IPO Opens Modeslty Lower

Today's IPO for Iterum Therapeutics plc (NASDAQ: ITRM) opened for trading at $12.70 after pricing 6,150,000 ordinary shares at a price to the public of $13.00 per share.

In addition, Iterum Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 922,500 ordinary shares to cover over-allotments, if any.

Leerink Partners and RBC Capital Markets are acting as joint book-running managers for the offering. Guggenheim Securities is acting as lead manager for the offering. Needham & Company is acting as co-manager for the offering.

You May Also Be Interested In

• Needham says State AGs delay on Paramount Skydance (PSKY) deal 'will NOT derail the deal'
• Samos Energy raises $230M in NYSE IPO for energy acquisitions
• Karooooo Ltd. (KARO) PT Raised to $70 at Needham